Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

HIV Infection

Free Subscription 28.03.2022 8 AIDS 2 AIDS Res Hum Retroviruses 2 Antimicrob Agents Chemother 1 BMC Cancer 2 BMJ 4 Clin Infect Dis 1 Drugs 5 HIV Med 4 J Acquir Immune Defic Syndr 2 J Clin Invest 1 J Clin Oncol 3 J Infect Dis 5 J Virol 2 Lancet 1 Lancet Infect Dis 1 MMWR Morb Mortal Wkly Rep 3 N Engl J Med 1 Neurology 1 PLoS Med 12 PLoS One 2 PLoS Pathog 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. GUANIRA JV, Fichtenbaum CJ
   Is it time to retire efavirenz as a first-line option worldwide?
   AIDS. 2022;36:317-318.
   PubMed        
   
   
2. JABS DA, Van Natta ML, Schneider MF, Pak JW, et al
   Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS.
   AIDS. 2022;36:177-184.
   PubMed         Abstract available
   
   
3. MURDOCH IG, Jacobs TG, Nieuwenhuize RM, van Rossum-Schornagel QC, et al
   Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity?
   AIDS. 2022;36:322-323.
   PubMed        
   
   
4. FILIP I
   Getting to the heart of the matter: the need for tailored cardiovascular prevention strategies in patients with HIV.
   AIDS. 2022;36:N1-N3.
   PubMed        
   
   
5. OLALLA-SIERRA J, Martin-Escalante MD, Garcia-Alegria J, Rubio-Rivas M, et al
   Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain.
   AIDS. 2022;36:683-690.
   PubMed         Abstract available
   
   
6. BERNARDINO JI, Srinivasa S
   Proprotein convertase subtilisin/kexin type 9 inhibitors: a turning point in HIV-associated dyslipidemia?
   AIDS. 2022;36:745-747.
   PubMed        
   
   
7. GENER AR, Kottilil S
   Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications.
   AIDS. 2022;36:749-750.
   PubMed        
   
   
8. MONTEJANO R, Marcelo C, Falces-Romero I, Del Valle LG, et al
   Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV.
   AIDS. 2022;36:751-753.
   PubMed        
   
   

   
   AIDS Res Hum Retroviruses

9. DUBE K, Eskaf S, Barr L, Palm D, et al
   Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause (IMAP) in the United States: Results from the AIDS Clinical Trials Group (ACTG) A5345 Biomarker Study.
   AIDS Res Hum Retroviruses. 2022 Mar 24. doi: 10.1089/AID.2021.0170.
   PubMed         Abstract available
   
   
10. SANGARLANGKARN A, Apornpong T, Woodard J, Jordan A, et al
    Correlation Between Polypharmacy and Frailty Among Thai Older Persons Living with HIV.
    AIDS Res Hum Retroviruses. 2022 Mar 24. doi: 10.1089/AID.2021.0214.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

11. MOORE K, Thakkar N, Magee M, Sevinsky H, et al
    Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants.
    Antimicrob Agents Chemother. 2022 Mar 22:e0225121. doi: 10.1128/aac.02251.
    PubMed         Abstract available
    
    
12. DIDE-AGOSSOU C, Bauman AA, Ramey ME, Rossmassler K, et al
    Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments.
    Antimicrob Agents Chemother. 2022 Mar 21:e0231021. doi: 10.1128/aac.02310.
    PubMed         Abstract available
    
    

    
    BMC Cancer

13. ZHAO Y, Kong LX, Feng FS, Yang J, et al
    A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:311.
    PubMed         Abstract available
    
    

    
    BMJ

14. BARKER J, Koeckerling D, Mudalige NL, Oyefeso O, et al
    Awake prone positioning for patients with covid-19.
    BMJ. 2022;376:o632.
    PubMed        
    
    
15. KAZATCHKINE M
    Ukrainian war: an economic crisis in Eastern Europe and Central Asia will lead to a health crisis.
    BMJ. 2022;376:o793.
    PubMed        
    
    

    
    Clin Infect Dis

16. COHEN CM, Wentzensen N, Lahrmann B, Tokugawa D, et al
    Automated evaluation of p16/Ki-67 dual stain cytology as a biomarker for detection of anal precancer in MSM living with HIV.
    Clin Infect Dis. 2022 Mar 24. pii: 6553198. doi: 10.1093.
    PubMed         Abstract available
    
    
17. INAGAKI K, Bradbury RS, Hobbs CV
    Hospitalizations Associated with Strongyloidiasis in the United States, 2003-2018.
    Clin Infect Dis. 2022 Mar 21. pii: 6551689. doi: 10.1093.
    PubMed         Abstract available
    
    
18. SURGERS L, Chiarabini T, Royer G, Rougier H, et al
    Evidence of sexual transmission of extended-spectrum beta-lactamase-producing Enterobacterales: a cross-sectional and prospective study.
    Clin Infect Dis. 2022 Mar 21. pii: 6551017. doi: 10.1093.
    PubMed         Abstract available
    
    
19. MCCALLUM AD, Pertinez HE, Chirambo AP, Sheha I, et al
    High intrapulmonary rifampicin and isoniazid concentrations are associated with rapid sputum bacillary clearance in patients with pulmonary tuberculosis.
    Clin Infect Dis. 2022 Mar 23. pii: 6553299. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Drugs

20. LAMB YN
    Nirmatrelvir Plus Ritonavir: First Approval.
    Drugs. 2022 Mar 19. pii: 10.1007/s40265-022-01692.
    PubMed         Abstract available
    
    

    
    HIV Med

21. FRANGE P, Avettand-Fenoel V, Veber F, Blanche S, et al
    No overall impact on body mass index for age change after dolutegravir initiation in a French paediatric cohort.
    HIV Med. 2022 Mar 20. doi: 10.1111/hiv.13302.
    PubMed         Abstract available
    
    
22. ANDERSEN MH, Alexander MT, Bintz C, Ford C, et al
    Medically assisted reproduction for people living with HIV in Europe: A cross-country exploratory policy comparison.
    HIV Med. 2022 Mar 22. doi: 10.1111/hiv.13269.
    PubMed         Abstract available
    
    
23. RYOM L, De Miguel R, Cotter AG, Podlekareva D, et al
    Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
    HIV Med. 2022 Mar 25. doi: 10.1111/hiv.13268.
    PubMed         Abstract available
    
    
24. LEE KW, Ang CS, Lim SH, Siau CS, et al
    Prevalence of mental health conditions among people living with HIV during the COVID-19 pandemic: A rapid systematic review and meta-analysis.
    HIV Med. 2022 Mar 18. doi: 10.1111/hiv.13299.
    PubMed         Abstract available
    
    
25. GEDELA K, Rajus N, Luis H, Fridayantara WD, et al
    Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia.
    HIV Med. 2022 Mar 21. doi: 10.1111/hiv.13298.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

26. GOEDEL WC, Coats CS, Chan PA, Sims-Gomillia CE, et al
    A Pilot Study of a Patient Navigation Intervention to Improve HIV Pre-Exposure Prophylaxis Persistence Among Black/African American Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2022 Mar 21. pii: 00126334-990000000-00010.
    PubMed         Abstract available
    
    
27. MENG W, Chen M, Song Y, Zhang H, et al
    Prevalence and Risk Factors of Low Bone Mineral Density in HIV/AIDS Patients: a Chinese Cross-sectional Study.
    J Acquir Immune Defic Syndr. 2022 Mar 22. pii: 00126334-990000000-00011.
    PubMed         Abstract available
    
    
28. WACHIRA J, Genberg B, Mwangi A, Chemutai D, et al
    Impact of an enhanced patient care (EPC) intervention on viral suppression among patients living with HIV in Kenya.
    J Acquir Immune Defic Syndr. 2022 Mar 23. pii: 00126334-990000000-00012.
    PubMed         Abstract available
    
    
29. PSOMAS CK, Hoover DR, Shi Q, Brown TT, et al
    POLYPHARMACY IS ASSOCIATED WITH FALLS IN WOMEN WITH AND WITHOUT HIV.
    J Acquir Immune Defic Syndr. 2022 Mar 25. pii: 00126334-990000000-00013.
    PubMed         Abstract available
    
    

    
    J Clin Invest

30. VARCO-MERTH BD, Brantley W, Marenco A, Duell DD, et al
    Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy.
    J Clin Invest. 2022 Mar 22. pii: 156063. doi: 10.1172/JCI156063.
    PubMed         Abstract available
    
    
31. FERRARI B, Da Silva AC, Liu KH, Saidakova EV, et al
    Gut-derived bacterial toxins impair memory CD4 T-cell mitochondrialfunction in HIV-1infection.
    J Clin Invest. 2022 Mar 22. pii: 149571. doi: 10.1172/JCI149571.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

32. RINER AN, Girma S, Vudatha V, Mukhopadhyay N, et al
    Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.
    J Clin Oncol. 2022 Mar 22:JCO2102492. doi: 10.1200/JCO.21.02492.
    PubMed         Abstract available
    
    

    
    J Infect Dis

33. TOVINH M, Horr G, Dobrikova K, Gotter C, et al
    Mitochondrial dysfunction contributes to impaired cytokine production of CD56 bright NK cells from HIV(+) individuals under effective antiviral therapy.
    J Infect Dis. 2022 Mar 21. pii: 6551690. doi: 10.1093.
    PubMed         Abstract available
    
    
34. WEI F, Xia N, Ocampo R, Goodman MT, et al
    Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies.
    J Infect Dis. 2022 Mar 23. pii: 6553063. doi: 10.1093.
    PubMed         Abstract available
    
    
35. REEVES RM, van Wijhe M, Lehtonen T, Stona L, et al
    A Systematic Review of European Clinical Practice Guidelines for Respiratory Syncytial Virus Prophylaxis.
    J Infect Dis. 2022 Mar 25. pii: 6554001. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

36. XIANG J, Lu M, Shi M, Cheng X, et al
    Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
    PubMed         Abstract available
    
    
37. LU F, Zankharia U, Vladimirova O, Yi Y, et al
    Epigenetic Landscape of HIV-1 Infection in Primary Human Macrophage.
    J Virol. 2022 Mar 23:e0016222. doi: 10.1128/jvi.00162.
    PubMed         Abstract available
    
    
38. HOTZEL I
    Deep-Time Structural Evolution of Retroviral and Filoviral Surface Envelope Proteins.
    J Virol. 2022 Mar 23:e0006322. doi: 10.1128/jvi.00063.
    PubMed         Abstract available
    
    
39. YERO A, Farnos O, Clain J, Zghidi-Abouzid O, et al
    Impact of Early ARV Initiation on Relative Proportions of Effector and Regulatory CD8 T Cell in Mesenteric Lymph Nodes and Peripheral Blood During Acute SIV Infection of Rhesus Macaques.
    J Virol. 2022 Mar 21:e0025522. doi: 10.1128/jvi.00255.
    PubMed         Abstract available
    
    
40. COGSWELL A, Jo S, Ferguson N, Gupta K, et al
    Presence of Natural Killer B Cells in Simian Immunodeficiency Virus-Infected Colon That Have Properties and Functions Similar to Those of Natural Killer Cells and B Cells but Are a Distinct Cell Population.
    J Virol. 2022 Mar 21:e0023522. doi: 10.1128/jvi.00235.
    PubMed         Abstract available
    
    

    
    Lancet

41. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    PubMed         Abstract available
    
    
42. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    PubMed        
    
    

    
    Lancet Infect Dis

43. YAN X, Jia Z, Zhang B
    Evaluating the risk compensation of HIV/AIDS prevention measures.
    Lancet Infect Dis. 2022;22:447-448.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

44. FISHER KA, Patel SV, Mehta N, Stewart A, et al
    Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:447-452.
    PubMed         Abstract available
    
    

    
    N Engl J Med

45. OZELO MC, Mahlangu J, Pasi KJ, Giermasz A, et al
    Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
    N Engl J Med. 2022;386:1013-1025.
    PubMed         Abstract available
    
    
46. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    PubMed        
    
    
47. JARVIS JN, Lawrence DS, Meya DB, Kagimu E, et al
    Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    N Engl J Med. 2022;386:1109-1120.
    PubMed         Abstract available
    
    

    
    Neurology

48. LAHOZ FERNANDEZ PE, Knak C, Freire MV, de Oliveira Pereira L, et al
    Orbital Plasmacytoma in a Young Patient With HIV Presenting as Multiple Cranial Nerve Palsy.
    Neurology. 2022 Mar 25. pii: WNL.0000000000200321.
    PubMed        
    
    

    
    PLoS Med

49. LE TOURNEAU N, German A, Thompson R, Ford N, et al
    Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003959.
    PubMed         Abstract available
    
    

    
    PLoS One

50. SPRENGER R, Hackl D, Kossack N, Schiffner-Rohe J, et al
    Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
    PLoS One. 2022;17:e0265433.
    PubMed         Abstract available
    
    
51. KEMP CG, Concepcion T, Ahmed HU, Anwar N, et al
    Baseline situational analysis in Bangladesh, Jordan, Paraguay, the Philippines, Ukraine, and Zimbabwe for the WHO Special Initiative for Mental Health: Universal Health Coverage for Mental Health.
    PLoS One. 2022;17:e0265570.
    PubMed         Abstract available
    
    
52. RASELLA D, Morais GAS, Anderle RV, Silva AFD, et al
    Evaluating the impact of social determinants, conditional cash transfers and primary health care on HIV/AIDS: Study protocol of a retrospective and forecasting approach based on the data integration with a cohort of 100 million Brazilians.
    PLoS One. 2022;17:e0265253.
    PubMed         Abstract available
    
    
53. HAZARD R, Bagenda D, Patterson AJ, Hoffman JT, et al
    Performance of the Universal Vital Assessment (UVA) mortality risk score in hospitalized adults with infection in Rwanda: A retrospective external validation study.
    PLoS One. 2022;17:e0265713.
    PubMed         Abstract available
    
    
54. CHAN AHY, Foot H, Pearce CJ, Horne R, et al
    Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0265715.
    PubMed         Abstract available
    
    
55. CONAN N, Simons E, Chihana ML, Ohler L, et al
    Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?
    PLoS One. 2022;17:e0265488.
    PubMed         Abstract available
    
    
56. FISEHA T, Ebrahim H, Ebrahim E, Gebreweld A, et al
    CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults.
    PLoS One. 2022;17:e0265740.
    PubMed         Abstract available
    
    
57. ALHARBEY RA, Aljahdaly NH
    On fractional numerical simulation of HIV infection for CD8+ T-cells and its treatment.
    PLoS One. 2022;17:e0265627.
    PubMed         Abstract available
    
    
58. NAI YH, Doeven EH, Guijt RM
    An improved nucleic acid sequence-based amplification method mediated by T4 gene 32 protein.
    PLoS One. 2022;17:e0265391.
    PubMed         Abstract available
    
    
59. ROJAS ROJAS T, Poizot-Martin I, Rey D, Duvivier C, et al
    Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
    PLoS One. 2022;17:e0261069.
    PubMed         Abstract available
    
    
60. FENTIE WENDIE T, Mengistu G
    Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study.
    PLoS One. 2022;17:e0265337.
    PubMed         Abstract available
    
    
61. YAZDANI K, Dolguikh K, Zhang W, Shayegi-Nik S, et al
    Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy.
    PLoS One. 2022;17:e0265811.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

62. JURCZYSZAK D, Manganaro L, Buta S, Gruber C, et al
    ISG15 deficiency restricts HIV-1 infection.
    PLoS Pathog. 2022;18:e1010405.
    PubMed         Abstract available
    
    
63. SHAHBAZ S, Okoye I, Blevins G, Elahi S, et al
    Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals.
    PLoS Pathog. 2022;18:e1010378.
    PubMed         Abstract available
    
    

    
    Vaccine

64. ISHII H, Nakamura-Hoshi M, Shu T, Matano T, et al
    Sendai virus particles carrying target virus glycoproteins for antibody induction.
    Vaccine. 2022 Mar 16. pii: S0264-410X(22)00273.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: